🔎 Trials Near Me

Home › Overweight › New York › New York City

Pag-aaral pangklinika para sa Overweight sa New York City, NY

19 pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng New York City (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients

Nagre-recruit
  • Weill Cornell -1300 York Avenue, New York
  • Lenox Hill Hospital | Northwell Health, New York
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07090005

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Nagre-recruitPhase 3
  • Weill Cornell Medicine - Comprehensive Weight Control Center, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07595549

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Nagre-recruitPhase 2
  • ALSA Research-Manhattan, New York
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Nagre-recruitPhase 3
  • Comprehensive Weight Ctrl Prog, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07720271

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Nagre-recruitPhase 3
  • New York Gastroenterology Associates, New York
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Nagre-recruitPhase 3
  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Nagre-recruitPhase 3
  • NYU Langone Health, New York
  • Weill Cornell Medical College, New York
  • IMA Clinical Research Manhattan, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07392190

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Nagre-recruitPhase 4
  • Equity Medical, New York
  • Care Access - Hoboken, Hoboken · 2 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06857942

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Nagre-recruitPhase 3
  • Kailera Clinical Site, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284901

Alpelisib Challenge Test (ACT)

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Columbia University Irving Medical Center, New York
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07778524

Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
  • Mexican Consulate's Ventanilla de Salud (VDS), New York
Edad 21 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05770570

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Nagre-recruitPhase 3
  • Icahn School of Medicine at Mount Sinai, New York
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07575399

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
  • Columbia University Irving Medical Center, New York
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06354088

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Nagre-recruitPhase 3
  • NYU Langone Orthopedic Center, New York
  • Hospital For Special Surgery, New York
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07509307

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Nagre-recruitMaagang Phase 1
  • Memorial Sloan Kettering Cancer Center, New York
Edad 18 pataas · Kababaihan · Na-update Abr 13, 2026 · NCT06751589

CHIME: Comparing Health Interventions for Maternal Equity

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Columbia University Medical Center, New York
  • NYU Langone Health, New York
Edad 18 pataas · Kababaihan · Na-update Mar 5, 2026 · NCT06724172

Effects of Ultra Processed Food on Intestinal Energy Harvest

Nagre-recruit
  • Columbia University Irving Medical Center, New York
Edad 25 pataas · Lahat ng kasarian · Na-update Okt 3, 2025 · NCT06853288

Pag-aaral para sa Overweight sa ibang lungsod

Iba pang pag-aaral sa New York City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.